The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Neonatal abstinence syndrome
Abstract
PURPOSE OF REVIEW: This review will discuss the complex nature of maternal and other factors that can affect the infant's display of neonatal abstinence syndrome (NAS), clinical presentation and treatment of NAS, and the impact of recent findings on future directions for research. RECENT FINDINGS: NAS has traditionally been described as a constellation of signs/symptoms displayed by the neonate upon withdrawal of gestational opioid exposure; however, recent research has advanced our understanding of this disorder. Other psychoactive substances, such as increasingly prescribed serotonin reuptake inhibitors, may produce an independent or synergistic discontinuation syndrome. The wide variability in NAS presentation has generated interest in the interplay of prenatal and postnatal environmental and genetic factors that may moderate or mediate its expression. Finally, recent advances in the treatment of opioid-dependent pregnant women have suggested buprenorphine as an alternative treatment to methadone during pregnancy, largely due to reduced NAS severity in exposed neonates. SUMMARY: Physicians should be aware of the complexity of the maternal, fetal, and infant factors that combine to create the infant's display of NAS, and incorporate these aspects into comprehensive assessment and care of the dyad. Further research regarding the pathophysiology and treatment of NAS is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005359 · Cited by 986
Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant
Iqbal, M. M., Sobhan, T., & Ryals, T. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.1.39 · Cited by 427 · cited 2×
“Infant withdrawal after benzodiazepine exposure can appear within a few days to 3 weeks after birth and last for several months [10].”
BackgroundDevlin, A. M., Brain, U., Austin, J., & Oberlander, T. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012201 · Cited by 308 · cited 2×
“early postnatal exposure to depressed mood has been associated with epigenetic changes in pregnant women and infants that may program behavior [25].”
BackgroundWikner, B. N., Stiller, C., Bergman, U., Asker, C., & Källén, B. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1457 · Cited by 253
Prenatal programming of postnatal plasticity?
Pluess, M., & Belsky, J. (2011) · Development and Psychopathology · doi:10.1017/s0954579410000623 · Cited by 235
Cited by
McQueen, K., & Murphy-Oikonen, J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600879 · Cited by 324
Treatment for substance use disorders in pregnant women: Motivators and barriers
Frazer, Z., McConnell, K., & Jansson, L. M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107652 · Cited by 215
Self-citationThe use of psychotropic medication during pregnancy: how about the newborn?
Kieviet, N., Honig, & Dolman (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s36394 · Cited by 100
Neuroanatomical characteristics of youths with prenatal opioid and poly-drug exposure
Nygaard, E., Slinning, K., Moe, V., Due-Tønnessen, P., Fjell, A., & Walhovd, K. B. (2018) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2018.04.004 · Cited by 58
Massey, S. H., Mroczek, D. K., Reiss, D., Miller, E. S., Jakubowski, J. A., Graham, E. K., Shisler, S. M., McCallum, M., Huestis, M. A., Ganiban, J. M., et al. (2018) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2018.06.002 · Cited by 27
Metadata
- Authors
- Jansson, L. M., & Velez, M.
- Venue
- Current Opinion in Pediatrics
- Published
- 2012-04
- Volume
- 24
- Issue
- 2
- Pages
- 252-258
- ISSN
- 1040-8703 (ISSN-L)
- OpenAlex
- W1982145810
- Cited by
- 165
- References
- 5
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neonatal abstinence syndrome. https://app.cochat.ai/papers/10.1097/mop.0b013e32834fdc3a
- The paper
- Jansson, L. M., & Velez, M. (2012). Neonatal abstinence syndrome. Current Opinion in Pediatrics. https://doi.org/10.1097/mop.0b013e32834fdc3a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.